- Home
- ZBIO vs CRMT Comparison
ZBIO vs CRMT Comparison
Compare ZBIO & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- CRMT
- Stock Information
- Founded
- ZBIO 2019
- CRMT 1981
- Country
- ZBIO United States
- CRMT United States
- Employees
- ZBIO N/A
- CRMT N/A
- Industry
- ZBIO
- CRMT Other Specialty Stores
- Sector
- ZBIO
- CRMT Consumer Discretionary
- Exchange
- ZBIO NYSE
- CRMT Nasdaq
- Market Cap
- ZBIO 389.2M
- CRMT 375.4M
- IPO Year
- ZBIO 2024
- CRMT N/A
- Fundamental
- Price
- ZBIO $8.43
- CRMT $47.62
- Analyst Decision
- ZBIO Strong Buy
- CRMT Hold
- Analyst Count
- ZBIO 7
- CRMT 3
- Target Price
- ZBIO $32.29
- CRMT $50.00
- AVG Volume (30 Days)
- ZBIO 197.8K
- CRMT 107.3K
- Earning Date
- ZBIO 05-16-2025
- CRMT 03-06-2025
- Dividend Yield
- ZBIO N/A
- CRMT N/A
- EPS Growth
- ZBIO N/A
- CRMT N/A
- EPS
- ZBIO N/A
- CRMT 1.04
- Revenue
- ZBIO $5,000,000.00
- CRMT $1,380,231,000.00
- Revenue This Year
- ZBIO N/A
- CRMT N/A
- Revenue Next Year
- ZBIO N/A
- CRMT $4.33
- P/E Ratio
- ZBIO N/A
- CRMT $45.75
- Revenue Growth
- ZBIO N/A
- CRMT N/A
- 52 Week Low
- ZBIO $5.83
- CRMT $36.40
- 52 Week High
- ZBIO $26.25
- CRMT $72.26
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- CRMT 54.55
- Support Level
- ZBIO N/A
- CRMT $43.41
- Resistance Level
- ZBIO N/A
- CRMT $50.49
- Average True Range (ATR)
- ZBIO 0.00
- CRMT 2.03
- MACD
- ZBIO 0.00
- CRMT 0.03
- Stochastic Oscillator
- ZBIO 0.00
- CRMT 59.46
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and in the majority of the cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.